Term Sheet

The latest on private equity, M&A, deals and movements — from Wall Street to Silicon Valley

The coming IPO parade

July 19, 2013: 10:47 AM ET

Eleven companies are on next week's IPO calendar.

FORTUNE -- It's been a busy few days for IPOs, and things only are expected to heat up next week.

Seven companies have priced on U.S. exchanges since Tuesday, including last night's $191 million raise for digital coupon marketplace RetailMeNot (SALE). It hopes to mimic the 60% aftermarket bump achieved yesterday by cancer "stem cell" company OncoMed Pharmaceuticals (OMED).

On tap next week are a whopping eleven offerings:


Next week's calender doesn't include anything huge, but it could be interesting to see if OncoMed provides any halo effect to any of the five VC-backed biotechs. I'd expect us to see some larger offerings come fall, which is when IPO volume traditionally increases.

Some additional IPO thoughts from an interview I did this morning on CNBC:

Posted in:
Join the Conversation
About This Author
Dan Primack
Dan Primack
Senior Editor, Fortune

Dan Primack joined Fortune.com in September 2010 to cover deals and dealmakers, from Wall Street to Sand Hill Road. Previously, Dan was an editor-at-large with Thomson Reuters, where he launched both peHUB.com and the peHUB Wire email service. In a past journalistic life, Dan ran a community paper in Roxbury, Massachusetts. He currently lives just outside of Boston.

Email a Tip | @danprimack | RSS
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Powered by WordPress.com VIP.